Aligned Genetics얼라인드
238120 · KOSDAQ · ₩238120 · 얼라인드
₩2,435▼ ₩90 (3.56%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 73.5% | 70.1% | 70.7% | 70.1% | 63.7% | 62.5% |
| Operating margin | 15.6% | 15.3% | 17.6% | 21.9% | 20.7% | 18.5% |
| Net margin | 28.7% | 18.2% | 26.2% | 21.3% | 17.0% | 47.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +0.9% | +1.5% | +3.7% | +10.6% | +16.9% | — |
| Operating income growth | +3.4% | −12.1% | −16.7% | +17.1% | +30.8% | — |
| Net income growth | +59.4% | −29.5% | +27.6% | +38.7% | −57.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 12.2% | 8.0% | 12.4% | 10.8% | 8.4% | 20.5% |
| Return on assets | 8.8% | 5.7% | 9.7% | 8.3% | 6.5% | 16.1% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 54.2% | 55.5% | 24.7% | 30.7% | 27.9% | 27.7% |
| Net debt to equity | 0.9% | −7.4% | −21.8% | −35.2% | −23.6% | −8.3% |
| Current ratio | 542.9% | 508.3% | 1,348.5% | 412.4% | 1,466.5% | 1,297.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Aligned Genetics / 얼라인드 / 238120 / KRX:238120
Source: KRX statistical information